William Skelly

Insider Reports History

Entity
Individual
Location
C/O Acura Pharmaceuticals, Inc., 616 N. North Court, Suite 120, Palatine, IL
Signature
/s/ William Skelly
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Skelly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ACURA PHARMACEUTICALS, INC Director Common Stock 576K Jan 2, 2024 Direct
ACURA PHARMACEUTICALS, INC Director Restricted Stock Units (2021 Plan) 50K Jan 2, 2024 Direct

Insider Reports Filed by William Skelly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACUR ACURA PHARMACEUTICALS, INC Jan 2, 2024 3 $0 4 Jan 2, 2024 Director
ACUR ACURA PHARMACEUTICALS, INC Jan 3, 2023 3 $0 4 Jan 5, 2023 Director
ACUR ACURA PHARMACEUTICALS, INC Jan 3, 2022 3 $0 4 Jan 5, 2022 Director
ACUR ACURA PHARMACEUTICALS, INC May 25, 2021 1 $0 4 May 28, 2021 Director